Xia Mao, Xiangying Yan, Congchong Li, Yudong Liu, Yanqiong Zhang, & Na Lin. (2023). Extensive preclinical evaluation of combined mangiferin and glycyrrhizic acid for restricting synovial neovascularization in rheumatoid arthritis. BMC.
Chicago Style (17th ed.) CitationXia Mao, Xiangying Yan, Congchong Li, Yudong Liu, Yanqiong Zhang, and Na Lin. Extensive Preclinical Evaluation of Combined Mangiferin and Glycyrrhizic Acid for Restricting Synovial Neovascularization in Rheumatoid Arthritis. BMC, 2023.
MLA (9th ed.) CitationXia Mao, et al. Extensive Preclinical Evaluation of Combined Mangiferin and Glycyrrhizic Acid for Restricting Synovial Neovascularization in Rheumatoid Arthritis. BMC, 2023.
Warning: These citations may not always be 100% accurate.